{
  "id": "medicine--medical-ethics--t-clinical-trial-diversity",
  "version": 1,
  "subject": "Medicine",
  "subcategory": "Medical Ethics",
  "course_id": "medicine--medical-ethics",
  "chapter_id": "medicine--medical-ethics--ch05-justice-and-access",
  "title": "Clinical Trial Diversity",
  "emoji": "âš–ï¸",
  "color": "#0891B2",
  "description": "A quick win: understand Clinical Trial Diversity.",
  "is_free": false,
  "published": true,
  "story": {
    "hook": {
      "text": "Most clinical trials over-represent white men. Drugs tested on one group may not work the same in others.",
      "visual": "ğŸ‘¥"
    },
    "buildup": {
      "text": "Historically, women, minorities, and elderly patients were excluded from trials that shaped treatment standards.",
      "visual": "ğŸš«"
    },
    "discovery": {
      "text": "Drug metabolism, dosing, and side effects can vary significantly by sex, age, and ethnicity.",
      "visual": "ğŸ§¬"
    },
    "twist": {
      "text": "Ambien's dose for women was cut in half in 2013 after years of overdosingâ€”it metabolizes more slowly in women.",
      "visual": "ğŸ’Š"
    },
    "climax": {
      "text": "Inclusive trials aren't just ethicalâ€”they produce safer, more effective medicine for everyone.",
      "visual": "âœ…"
    },
    "punchline": {
      "text": "Medicine for everyone must be tested on everyone.",
      "visual": "ğŸŒ"
    }
  },
  "quiz": {
    "question": "Why was Ambien's dose for women changed in 2013?",
    "options": [
      "Women metabolize it more slowly, leading to years of overdosing",
      "Men were found to need a higher dose for the same effect",
      "The drug was reformulated with different ingredients"
    ],
    "correct": 0
  }
}
